PCI Biotech Holding

Less than 1K followers

PCIB

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

PCI Biotech Holding is a biopharmaceutical group, where most of the operations are conducted within the subsidiary PCI Biotech. The group is engaged in the development of therapeutic products based on the proprietary PCI technology. The solutions are intended for use in the treatment of cancer patients. PCI Biotech was originally founded in 2000 as a subsidiary of Photocure and is headquartered in Oslo, Norway.

Market cap

-

Turnover

-

Revenue

6.74M

EBIT %

-266.47 %

P/E

-

Dividend yield-%

-

Financial calendar

16/3

2026

Extraordinary general meeting '26

All

Press releases

ShowingAll content types

Regulatory press release2/23/2026, 12:17 PM

Notice of Extraordinary General Meeting, proposed company dissolution and delisting

PCI Biotech Holding

Regulatory press release1/30/2026, 9:34 AM

PCIB: PCI Biotech Holding ASA is placed in Recovery Box

PCI Biotech Holding

Regulatory press release1/29/2026, 4:49 PM

PCI Biotech initiates a process to evaluate the opportunity for a structured wind-up process

PCI Biotech Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release1/8/2026, 1:10 PM

PCI Biotech announces discontinuation of R&D operations and continues evaluation of future options

PCI Biotech Holding

Regulatory press release10/23/2025, 8:35 AM

PCI Biotech update

PCI Biotech Holding

Regulatory press release9/25/2025, 1:36 PM

PCI Biotech update on future operations

PCI Biotech Holding

Regulatory press release8/29/2025, 5:00 AM

PCI Biotech half-year interim 2025 report

PCI Biotech Holding

Regulatory press release8/26/2025, 2:14 PM

PCI Biotech: Invitation to first half 2025 results presentation and corporate update

PCI Biotech Holding

Regulatory press release8/22/2025, 12:15 PM

PCIB: Flaggemelding

PCI Biotech Holding

Regulatory press release8/22/2025, 12:15 PM

Flaggemelding

PCI Biotech Holding

Regulatory press release8/22/2025, 9:09 AM

PCIB: Flaggemelding

PCI Biotech Holding

Regulatory press release8/22/2025, 9:09 AM

Flaggemelding

PCI Biotech Holding

Regulatory press release8/18/2025, 6:39 PM

PCI Biotech announces discontinuation of development of the PCL technology and evaluation of future operations

PCI Biotech Holding

Regulatory press release5/22/2025, 9:45 AM

PCI Biotech: Minutes of Annual General Meeting 2025

PCI Biotech Holding

Regulatory press release5/20/2025, 8:08 PM

PCI BIotech: Disclosure of voting rights for Chair of the Board

PCI Biotech Holding

Regulatory press release4/30/2025, 8:00 AM

Notice of Annual General Meeting 2025

PCI Biotech Holding

Regulatory press release4/24/2025, 3:30 PM

PCI Biotech Holding ASA: Annual Report 2024

PCI Biotech Holding

Regulatory press release2/27/2025, 6:00 AM

PCI Biotech full year 2024 interim results

PCI Biotech Holding

Regulatory press release2/25/2025, 7:56 AM

PCI Biotech: Invitation to preliminary full-year 2024 results presentation

PCI Biotech Holding

Regulatory press release1/10/2025, 9:24 AM

PCI Biotech: Employee share option scheme in connection with promotion of new CSO

PCI Biotech Holding

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.